|
Anthrax |
| Ciprofloxacin |
500mg PO q12h for 60 days |
| Doxycycline |
100mg PO q12h for 60 days |
| Vaccine |
PPT Presentation Anthrax Vaccine |
|
|
Botulism |
No PEP available |
|
Plague |
| Doxycycline |
100mg PO q12h for 7 days |
|
|
Smallpox |
Vaccination within 4 days of exposure |
|
Tularemia |
-
Persons beginning treatment with
streptomycin, gentamicin, doxycycline, or
ciprofloxacin in the incubation period of
tularemia and continuing treatment daily for
14 days might be protected against
symptomatic infection. Therefore, if an
attack is discovered before individuals
become ill, exposed persons should be
prophylactically treated with 14 days of
oral doxycycline or ciprofloxacin.
-
If an attack is discovered only after
individuals become ill, persons potentially
exposed should begin a fever watch. Those
who develop an otherwise unexplained fever
or flu-like illness within 14 days of
presumed exposure should begin treatment as
outlined above.
-
Postexposure prophylactic treatment of close
contacts of tularemia patients is not
recommended because person-to-person
transmission is not known to occur.
|
|
| Doxycycline |
100mg PO q12h for 14 days |
| Ciprofloxacin |
500mg PO q12h for 14 days |
|
|
Viral Hemorrhagic fevers |
No PEP available for most VHF. PEP for Lassa Fever:
ribavirin used with some protective effects in case contacts.
Yellow Fever vaccine not effective after BT event. |
